Raymond James & Associates’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-584
| Closed | -$7K | – | 3791 |
|
|
2022
Q3 | $7K | Buy |
+584
| New | +$7K | ﹤0.01% | 3776 |
|
|
2020
Q3 | – | Sell |
-692
| Closed | -$51K | – | 3474 |
|
|
2020
Q2 | $51K | Buy |
+692
| New | +$51K | ﹤0.01% | 3318 |
|
|
2020
Q1 | – | Sell |
-588
| Closed | -$45K | – | 3426 |
|
|
2019
Q4 | $45K | Sell |
588
-62
| -10% | -$4.75K | ﹤0.01% | 3493 |
|
|
2019
Q3 | $26K | Sell |
650
-12,100
| -95% | -$484K | ﹤0.01% | 3456 |
|
|
2019
Q2 | $428K | Sell |
12,750
-2,233
| -15% | -$75K | ﹤0.01% | 2772 |
|
|
2019
Q1 | $794K | Sell |
14,983
-1,585
| -10% | -$84K | ﹤0.01% | 2334 |
|
|
2018
Q4 | $779K | Buy |
16,568
+4,578
| +38% | +$215K | ﹤0.01% | 2231 |
|
|
2018
Q3 | $1.06M | Buy |
11,990
+2,196
| +22% | +$193K | ﹤0.01% | 2223 |
|
|
2018
Q2 | $1.02M | Buy |
9,794
+4,996
| +104% | +$520K | ﹤0.01% | 2198 |
|
|
2018
Q1 | $384K | Buy |
4,798
+3,549
| +284% | +$284K | ﹤0.01% | 2721 |
|
|
2017
Q4 | $170K | Sell |
1,249
-311
| -20% | -$42.3K | ﹤0.01% | 3086 |
|
|
2017
Q3 | $253K | Buy |
1,560
+314
| +25% | +$50.9K | ﹤0.01% | 2877 |
|
|
2017
Q2 | $187K | Buy |
+1,246
| New | +$187K | ﹤0.01% | 2972 |
|